At GMPriority Pharma, we’re committed to science-backed innovation and integrity in liposomal formulation. In recent months, we’ve observed a troubling trend: myths and misinformation being spread about dry (powdered) liposomes, especially within the food supplement industry. Contract manufacturers without the level of expertise in nanoencapsulation claim: “Only liquid liposomal formulations preserve the full integrity and […]
Collagen is the most abundant protein in the human body, forming the structural framework for skin, joints, bones, and connective tissues. As we age, collagen production declines, leading to wrinkles, joint pain, and reduced bone strength. External factors such as UV radiation, smoking, and poor diet can accelerate this decline, making collagen supplementation an attractive […]
16th January 2025 GMPriority Pharma Wins “Best Liposome Research & Development Company” at the Global Health & Pharma Healthcare & Pharmaceuticals Awards 2024 We are thrilled to announce that GMPriority Pharma has been recognised as the “Best Liposome Research & Development Company” at the prestigious Global Health & Pharma Magazine Healthcare & Pharmaceuticals Awards 2024. […]
Best of the Best 27th November 2024. It was a great privilege to attend the Innovate UK Knowledge Transfer Partnership Awards 2024 in Birmingham on 27th November. It is, in itself, a tremendous honour to have our Knowledge Transfer Partnership project graded as “Outstanding” by Innovate UK. Furthermore, being selected as a finalist for the KTP […]
24th July 2024 Scientific Integrity in Nutraceutical Formulations GMPriority Pharma have today been recognised for our work in campaigning for integrity and truth in the labelling of food supplements. Over the past five years, we have proactively characterised multiple commercial liposomal supplements. We have amassed a library of data, which calls into question the legitimacy […]
Meeting Disulfican Ltd Our Chief Scientist, Professor Mohammad Najlah was delighted to host Professor Weiguang Wang, from the University of Wolverhampton and Vinodh Kannappan, Chief Technology Officer at Disulfican Ltd, to his Anglia Ruskin University labs. During their visit, the group explored numerous opportunities to strengthen their long-term collaboration. Professor Najlah also toured the visitors […]
GMPriority Pharma Unveils Groundbreaking Innovation in Liposomal Dry Powder Technology with Successful Scale-Up of dry SAIFx® GMPriority Pharma is thrilled to announce the successful scale-up of our pioneering liposomal dry powder technology, dry SAIFx®, following a highly productive two-year Research and Development Knowledge Transfer Partnership (KTP) with Anglia Ruskin University. This innovative advancement marks a […]
GMPriority Pharma facility achieves GMP status We are proud to announce that GMPriority Pharma has achieved the prestigious Good Manufacturing Practice (GMP) status, certified by NQA. This significant milestone underscores our continued commitment to maintaining the highest standards of quality and safety in the research and manufacturing of innovative liposomal products. What is GMP and […]
KTP Project Awarded “Outstanding” Grade lipolife, a leading, innovative brand in liposomal health supplements, is proud to announce that it has been awarded an “Outstanding” grade by Innovate UK for its Knowledge Transfer Partnership (KTP) with Anglia Ruskin University. This prestigious recognition underscores our commitment to advancing scientific excellence and innovation in liposomal technology. Innovate […]
GMPriority Pharma wins Pharmaceutical Company of the Year The accolade was accepted at the Corporate Livewire Awards in Surrey in the Innovation and Excellence category, 2023. Surrey – 06/09/2023 GMPriority Pharma are delighted to have received the prestigious Corporate Livewire Award for Pharmaceutical Company of the Year (2023) in the Innovation and Excellence category. The […]